Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Journal Mobile Options
Table of Contents
Vol. 55, No. 1, 2009
Issue release date: January 2009
Section title: Clinical Section
Free Access
Gerontology 2009;55:3–12

Osteoporosis: An Age-Related and Gender-Specific Disease – A Mini-Review

Pietschmann P.a, b · Rauner M.b, c · Sipos W.d · Kerschan-Schindl K.e
aDepartment of Pathophysiology, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, and bLudwig Boltzmann-Institute of Aging Research, Vienna, Austria; cDivision of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, Technical University, Dresden, Germany; d2nd Medical Clinic, University of Veterinary Medicine Vienna, and eDepartment of Physical Medicine and Rehabilitation, Medical University of Vienna, Vienna, Austria
email Corresponding Author

Dr. Peter Pietschmann, MD

Department of Pathophysiology, Center of Physiology and Pathophysiology

Medical University of Vienna, Währinger Gürtel 18–20, AT–1090 Vienna (Austria)

Tel. +43 140 400 5122, Fax +43 140 400 5130

E-Mail peter.pietschmann@meduniwien.ac.at


  1. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R: European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399–428.
  2. Melton LJ, Chrischilles EA, Lane AW, Riggs BL: Perspective: how many women have osteoporosis? J Bone Miner Res 1992;7:1005–1010.
  3. O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ: The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. J Bone Miner Res 1996;11:1010–1018.
  4. Jackson SA, Tenenhouse A, Robertson L: Vertebral fracture definition from population-based data: preliminary results from the Canadian multicenter osteoporosis study. Osteoporos Int 2000;11:680–687.
  5. Van Helden S, van Geel AC, Geusens PP, Kessels A, Nieuwenhuijzen Kruseman AC, Brink PR: Bone and fall-related fracture risks in women and men with a recent clinical fracture. J Bone Joint Surg Am 2008;90:241–248.
  6. Cree M, Soskolne CL, Belseck E, Hornig J, Mc Elhaney JE, Brant R, Suarez-Almazor M: Mortality and institutionalization following hip fracture. J Am Geriatr Soc 2000;48:283–288.
  7. Rauner M, Sipos W, Pietschmann P: Osteoimmunology. Int Arch Allergy Immunol 2007;143:31–48.
  8. Sipos W, Pietschmann P, Rauner M: Strategies for novel therapeutic approaches targeting cytokines and signalling pathways of osteoclasto- and osteoblastogenesis in the fight against immune-mediated bone and joint diseases. Curr Med Chem 2008;15:127–136.
  9. Mundy GR, Elefteriou F: Boning up on ephrin signaling. Cell 2006;126:441–443.
  10. Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ: Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 1996;11:568–577.
  11. Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC: Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996;97:1732–1740.
  12. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747–754.
  13. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B: Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004;3:379–389.
  14. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Lévy N: Lamin a truncation in Hutchinson-Gilford progeria. Science 2003;300:2055.
  15. Rauner M, Sipos W, Foisner R, Hofbauer L, Pietschmann P: Silencing lamin A/C decreases osteoblast differentiation and stimulates osteoclastogenesis through enhanced RANKL signaling. Calcified Tissue Int 2008;82:50–51.
  16. Perkins SL, Gibbons R, Kling S, Kahn AJ: Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone 1994;15:65–72.
  17. Cao J, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP: Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res 2005;20:1659–1668.
  18. Pietschmann P, Skalicky M, Kneissel M, Rauner M, Hofbauer G, Stupphann D, Viidik A: Bone structure and metabolism in a rodent model of male senile osteoporosis. Exp Gerontol 2007;42:1099–1108.
  19. Kerschan-Schindl K, Wendlova J, Kudlacek S, Gleiss A, Woloszczuk W, Pietschmann P: Serum levels of receptor activator of nuclear factor kappaB ligand (RANKL) in healthy women and men. Exp Clin Endocrinol Diabetes 2008;116:491–495.
  20. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S: Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 1988;3:133–144.
  21. Szulc P, Delmas PD: Biochemical markers of bone turnover in osteoporosis; in Marcus R, Feldman D, Nelson DA, Rosen CF (eds): Osteoporosis, ed 3. Amsterdam, Elsevier, 2008, vol 2, pp 1519–1545.
  22. Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M, Woloszczuk W, Peterlik M, Tragl KH: The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol 2003;38:1119–1127.
  23. Riggs BL, Khosla S, Melton LJ 3rd: A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763–773.
  24. Schiller C, Gruber R, Redlich K, Oberhollenzer F, Weger S, Egger G, Mayr A, Jocher J, Xu Q, Pietschmann P, Teitelbaum S, Smolen J, Willeit J: 17β-Estradiol antagonizes effects of 1α,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Endocrinology 1997;138:4567–4571.
  25. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL: Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003;111:1120–1122.
  26. Pacifici R: Postmenopausal osteoporosis: how the hormonal changes of menopause cause bone loss; in Marcus R, Feldman D, Nelson DA, Rosen CF (eds): Osteoporosis, ed 3. Amsterdam, Elsevier, 2008, vol 2, pp 1041–1054.
  27. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G: Inflamm-aging: an evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000;908:244–254.
  28. Riggs BL, Khosla S, Melton J 3rd: Estrogen, bone homeostasis, and osteoporosis; in Marcus R, Feldman D, Nelson DA, Rosen CF (eds): Osteoporosis, ed 3. Amsterdam, Elsevier, 2008, vol 2, pp 1012–1039.
  29. Pietschmann P, Kudlacek S, Grishar J, Spitzauer S, Woloszczuk W, Willvonseder R, Peterlik M: Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 2001;31:444–451.
  30. Bouxsein ML: Bone quality: where do we go from here? Osteoporos Int 2003;14:S118–S127.
  31. Seeman E: Bone quality: the material and structural basis of bone strength. J Bone Miner Res 2008;26:1–8.
    External Resources
  32. Melton LJ 3rd, Riggs BL, van Lenthe GH, et al: Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res 2007;22:1442–1448.
  33. Seeman E: Periosteal bone formation: a neglected determinant of bone strength. N Engl J Med 2003;349:320–323.
  34. Beck TJ, Looker AC, Mourtada F, Daphtary MM, Ruff CB: Age trends in femur stresses from a simulated fall on the hip among men and women: evidence of homeostatic adaptation underlying the decline in hip BMD. J Bone Miner Res 2006;21:1425–1432.
  35. Bonel HM, Lochmüller EM, Well H, Kuhn V, Hudelmaier M, Reiser M, Eckstein F: Multislice computed tomography of the distal radius metaphysis: relationship of cortical bone structure with gender, age, osteoporotic status, and mechanical competence. J Clin Densitom 2004;7:169–182.
  36. Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delmas PD: Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res 2006;21:1856–1863.
  37. Gilsanz V, Boechat MI, Gilsanz R, Loro ML, Roe, TF, Goodman WG: Gender differences in vertebral sizes in adults: biomechanical implications. Radiology 1994;190:678–682.
  38. Duan Y, Turner CH, Kim BT, Seeman E: Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss. J Bone Miner Res 2001;16:2267–2275.
  39. Yang RS, Lin HJ, Chieng PU, Liu TK, Tsai KS: Estimated risk score for spine fracture in the specific bending activity of normal Taiwanese men and women. Spine 2005;30:2288–2292.
  40. Bouxsein ML, Melton LJ 3rd, Riggs BL, Muller J, Atkinson EJ, Oberg AL, Robb RA, Camp JJ, Rouleau PA, McCollough CH, Khosla S: Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res 2006;21:1475–1482.
  41. Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–1707.
  42. Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC: Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. J Am Med Assoc 1994;271:128–133.
  43. Smeesters C, Hayes WC, McMahon TA: Disturbance type gait speed affect fall direction and impact location. J Biomech 2001;34:309–317.
  44. De Laet C, Kanis JA, Oden A, et al: Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16:1330–1338.
  45. Hayes WC, Myers ER, Robinovitch SN, Van Den Kroonenberg A, Courtney AC, McMahon TA: Etiology and prevention of age-related hip fractures. Bone 1996;18:77–86.
    External Resources
  46. Bouxsein ML, Szulc P, Munoz F, Thrall E, Sornay-Rendu E, Delmas PD: Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture risk. J Bone Miner Res 2007;22:825–831.
  47. Riggs BL, Parfitt AM: Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 2005;20:177–184.
  48. Blahos J: Treatment and prevention of osteoporosis. Wien Med Wochenschr 2007;157/ 23–24:589–592.
    External Resources
  49. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A: Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604–610.
  50. Reid DM, Adami S, Devogelaer JP, Chines AA: Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int 2001;69:242–247.
  51. Ringe JD, Faber H, Farahmand P, Dorst A: Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 2006;26:427–431.
  52. Seeman E: An exercise in geometry. J Bone Mineral Res 2002;17:373–380.
  53. Wallace JM, Rajachar RM, Allen MR, Bloomfield SE, Robey PG, Young MF, Kohn DH: Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone 2007;40:1120–1127.
  54. Hulme PA, Krebs J, Ferguson SJ, Berlemann U: Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine 2006;31:1983–2001.
  55. Parker MJ, Gillespie WJ, Gillespie LD: Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2005;3:CD001255.
  56. Oliver D, Conelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, Vanoli A, Martin FC, Gosney MA: Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. Br Med J 2007;334:82–85.
  57. Van Schoor NM, Smit JH, Bouter LM, Veenings B, Asma GB, Lips P: Maximum potential preventive effect of hip protectors. J Am Geriatr Soc 2007;55:507–510.
  58. Holzer L, Holzer G: Die Bedeutung von Hüftprotektoren zur Prävention von hüftnahen Frakturen bei älteren Menschen. Wien Med Wochenschr 2007;157:381–387.
  59. Laing AC, Robinovitch SN: Effect of soft shell hip protectors on pressure distribution to the hip during sideways falls. Osteoporos Int 2008;19:1067–1075.